摘要
随着“互联网+”战略的实施,以互联网为媒介的药品交易呈现迅猛发展的势头,同时也伴生一系列新问题,而因其交易所具有的特殊性也使得法律监管呈现缺失的情况,故为进一步完善我国互联网药品交易监管体系,建议明晰互联网药品信息管理细则,规范药品第三方物流监管制度,药监局、行业协会及社会团体和消费者共同形成监管合力。
With the implementation of the"Internet+"strategy,drug trading with Internet as the medium presents a momentum of rapid development,but also a series of new problems,and the particularity of its exchange leads to the lack of legal supervision,there⁃fore,in order to further improve Internet drug trading regulatory system in China,it is suggested to clarify the Internet drug information management rules,standardize the drug third-party logistics supervision system,and jointly form a regulatory force of the drug adminis⁃tration,industry associations,social groups and consumers.
作者
葛柳茹
王萍
姜鑫
徐晗宇
GE Liuru;WANG Ping;JIANG Xin;XU Hanyu(Law School of Xi'an University of Finance and Economics,Xi'an,Shaanxi 710100,China;Humanities and Social Sciences School of Harbin Medical University,Harbin,Heilongjiang 150081,China)
出处
《医学与法学》
2024年第1期105-109,共5页
Medicine and Jurisprudence
基金
四川医事卫生法治研究中心课题“重大突发事件中推进法治政府建设之信息公开制度研究”(项目编号:YF21-Y16)
“卫生健康领域法律治理体系的构建研究”(项目编号:YF20-Z04)的阶段性成果。
关键词
互联网+
药品交易
法律监管
第三方平台
Internet+
drug trade
legal supervision
the third party platform
